logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Pharmaceutical
Filter

Pharmaceutical

Categories

Sectors

Locations

Exchange

英伟达之后,博通将成为下一个2万亿美元芯片巨头

Towards 2026, Focusing on Three High-Potential Biotechnology Companies

Dec 29, 2025

Life Science

CRISPR Therapeutics Soars as Partner Vertex Drops Optimistic 2026 Sales Guidance

Can These Two Battered Biotech Stocks Stage a Comeback in 2026?

Dec 29, 2025

Life Science

Who Will Lead in 2026? Analysts Identify the Next Cohort of U.S. Growth Stocks

Who Will Lead in 2026? Analysts Identify the Next Cohort of U.S. Growth Stocks

Dec 28, 2025

Financial Service, Life Science, Technology

Bold Forecast: Executive Order Paves Way for Federal Cannabis Legalization by 2026

Bold Forecast: Executive Order Paves Way for Federal Cannabis Legalization by 2026

Dec 28, 2025

Cannabis

药物获批与收购潜力形成“双击”,Travere Therapeutics股价获强劲助推

Drug Approval and Acquisition Potential Form a “Double Boost,” Providing Strong Momentum for Travere Therapeutics’ Stock Price

Dec 24, 2025

Life Science

Apple Stock Is Down 9% This Year. History Says It’s a Buying Opportunity

Looking for a “Forever” Stock? These 2 Healthcare Picks Are Worth Considering

Dec 24, 2025

Life Science

逆市大涨!生物技术公司格劳科斯股价飙升近14%

The Logic Behind Institutions’ Heavily Weighted and Counter-Cyclical Increase in Holdings of Lantheus 

Dec 24, 2025

Life Science

Apple May Have Finally Found Its Floor

Oral Obesity Pill Arrives: Has Novo Nordisk Stock Finally Hit Bottom?

Dec 23, 2025

Life Science

Why Eli Lilly Is Underrated in the Red-Hot GLP-1 Weight-Loss Drug Race, per Morgan Stanley

Looking Beyond Novo Nordisk, High-Yield Pfizer Is a Bigger Contrarian Opportunity

Dec 22, 2025

Life Science

医疗保健股冰火两重天:一支潜力股与两支需观察的股票

Who Will Lead the Future? Predictions for Healthcare Companies with the Greatest Growth Potential in 2026 

Dec 19, 2025

Life Science

联合健康与礼来,谁将引领市场?

UnitedHealth Group vs. Eli Lilly: Who Will Lead the Market?

Dec 18, 2025

Life Science

Trump Signs Historic Cannabis Order, But Stock Reaction Tells a More Complex Story

Trump Signs Historic Cannabis Order, But Stock Reaction Tells a More Complex Story

Dec 18, 2025

Cannabis

AI Rewrites Drug Discovery: Eli Lilly and Twist Bioscience Chart Two Distinct Industrialization Paths

Backed by Nvidia, Recursion Soars 11% Following Bullish Analyst Call and Clinical Trial Update

Dec 17, 2025

Life Science, Technology

“黑色星期五”突袭,美股牛市引擎熄火?

Healthcare Supply Giant Medline Lands on Nasdaq, Raises $6.26 Billion in the Year’s Largest IPO

Dec 17, 2025

Life Science

把握市场波动,两只得投资的加拿大股票

Medical Giant Medline Successfully Lands on Nasdaq, Igniting a New Wave of IPO Frenzy

Dec 16, 2025

Life Science

投资基因编辑疗法公司CRISPR Therapeutics (CRSP) 的核心理由

Two Engines Drive the Future, Market Continues Betting on Lilly

Dec 15, 2025

Life Science

2x Valuation Gap: BIO vs. CRL — Who’s Wrong?

Immunome Soars 15% as Phase 3 Trial of Desmoid Tumor Drug Achieves Overwhelming Success

Dec 15, 2025

Life Science

2025年值得关注的三只金融科技股票

Which Healthcare Stocks Will Stand Out in 2026?

Dec 12, 2025

Life Science

  • ‹‹ Previous
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada